By delivering mRNA into a cell, the cell could be induced to produce any protein encoded by the mRNA. The protein produced can be used for medical prevention or treatment. The translatability and stability of mRNA as well as its immunostimulatory activity are the key factors to be optimized for specific therapeutic application. mRNA holds the potential to revolutionize vaccination, protein replacement therapies, and the treatment of genetic diseases.
This report contains market size and forecasts of mRNA Therapy in Global, including the following market information:
Global mRNA Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global mRNA Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of mRNA Therapy include Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc., Astrazeneca and CureVac, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the mRNA Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global mRNA Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global mRNA Therapy Market Segment Percentages, by Type, 2021 (%)
Vaccine
Drugs
Global mRNA Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global mRNA Therapy Market Segment Percentages, by Application, 2021 (%)
mRNA Targeted Delivery in vivo
Genetically Modified T cells
Transforming Nanoparticles to Develop Immunotherapy for Cancer
Small Molecule Drugs Discovery
Global mRNA Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global mRNA Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies mRNA Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies mRNA Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Moderna
BioNTech
Pfizer
Arcturus Therapeutics Holdings Inc.
Astrazeneca
CureVac